BOUT vs. SCHM

Last updated Jun 24, 2026

BOUT (Innovator IBD Breakout Opportunities ETF) and SCHM (Schwab US Mid-Cap ETF) are both exchange-traded funds - BOUT is a Mid Cap Growth Equities fund tracking the IBD Breakout Stocks Total Return Index, while SCHM is a Mid Cap Blend Equities fund tracking the Dow Jones US Total Stock Market Mid-Cap. Both are passively managed. Over the past 5 years, BOUT returned 8.29%/yr vs 8.08%/yr for SCHM. A 0.75 correlation means they provide meaningful diversification when combined. BOUT charges 0.80%/yr vs 0.04%/yr for SCHM.

Performance

BOUT vs. SCHM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator IBD Breakout Opportunities ETF (BOUT) and Schwab US Mid-Cap ETF (SCHM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BOUT achieves a 31.88% return, which is significantly higher than SCHM's 19.11% return.

BOUT

• 1D: -1.91%
• 1M: 3.56%
• YTD: 31.88%
• 6M: 28.55%
• 1Y: 34.68%
• 3Y*: 16.89%
• 5Y*: 8.29%
• 10Y*: —

SCHM

• 1D: -1.73%
• 1M: 2.88%
• YTD: 19.11%
• 6M: 16.97%
• 1Y: 31.33%
• 3Y*: 17.85%
• 5Y*: 8.08%
• 10Y*: 11.71%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BOUT vs. SCHM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
BOUT Innovator IBD Breakout Opportunities ETF	31.88%	-6.77%	18.82%	13.27%	-22.60%	22.69%	50.56%	20.59%	-30.42%
SCHM Schwab US Mid-Cap ETF	19.11%	10.17%	11.98%	16.69%	-17.07%	19.36%	15.26%	27.48%	-17.25%

Correlation

The correlation between BOUT and SCHM is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.78
Correlation (3Y) Calculated over the trailing 3-year period	0.81
Correlation (5Y) Calculated over the trailing 5-year period	0.79
Correlation (All Time) Calculated using the full available price history since Sep 13, 2018	0.75

The correlation between BOUT and SCHM has been stable across timeframes, ranging from 0.75 to 0.81 - a consistent structural relationship.

BOUT vs. SCHM - Sectors Allocation Comparison

Sectors	BOUT	SCHM
Technology	33.0%	22.1%
Financial Services	18.3%	10.9%
Basic Materials	12.3%	4.7%
Consumer Cyclical	10.8%	10.8%
Utilities	7.0%	2.9%
Healthcare	6.5%	10.9%
Consumer Defensive	4.8%	3.4%
Energy	4.0%	3.4%
Real Estate	3.9%	6.4%
Communication Services	3.3%	2.6%
Industrials	3.2%	21.7%

Return for Risk

BOUT vs. SCHM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOUT

BOUT Risk / Return Rank: 51
BOUT Sharpe Ratio Rank: 49
BOUT Sortino Ratio Rank: 45
BOUT Omega Ratio Rank: 45
BOUT Calmar Ratio Rank: 64
BOUT Martin Ratio Rank: 54

SCHM

SCHM Risk / Return Rank: 64
SCHM Sharpe Ratio Rank: 60
SCHM Sortino Ratio Rank: 60
SCHM Omega Ratio Rank: 56
SCHM Calmar Ratio Rank: 70
SCHM Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BOUT vs. SCHM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and Schwab US Mid-Cap ETF (SCHM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BOUT	SCHM	Difference
Sharpe ratio: Return per unit of total volatility	1.59	1.93	-0.34
Sortino ratio: Return per unit of downside risk	2.17	2.72	-0.55
Omega ratio: Gain probability vs. loss probability	1.28	1.34	-0.06
Calmar ratio: Return relative to maximum drawdown	2.96	3.38	-0.42
Martin ratio: Return relative to average drawdown	8.76	13.48	-4.72

BOUT vs. SCHM - Sharpe Ratio Comparison

The current BOUT Sharpe Ratio is 1.59, which is comparable to the SCHM Sharpe Ratio of 1.93. The chart below compares the historical Sharpe Ratios of BOUT and SCHM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BOUT vs. SCHM - Drawdown Comparison

The maximum BOUT drawdown since its inception was -36.98%, smaller than the maximum SCHM drawdown of -42.43%. Use the drawdown chart below to compare losses from any high point for BOUT and SCHM.

Drawdown Indicators

	BOUT	SCHM	Difference
Max Drawdown Largest peak-to-trough decline	-36.98%	-42.43%	+5.45%
Max Drawdown (1Y) Largest decline over 1 year	-11.76%	-9.32%	-2.44%
Max Drawdown (3Y) Largest decline over 3 years	-25.31%	-23.27%	-2.04%
Max Drawdown (5Y) Largest decline over 5 years	-28.28%	-26.46%	-1.82%
Max Drawdown (10Y) Largest decline over 10 years	—	-42.43%	—
Current Drawdown Current decline from peak	-1.91%	-1.73%	-0.18%
Average Drawdown Average peak-to-trough decline	-12.29%	-5.64%	-6.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.97%	2.33%	+1.64%

Volatility

BOUT vs. SCHM - Volatility Comparison

Innovator IBD Breakout Opportunities ETF (BOUT) has a higher volatility of 8.27% compared to Schwab US Mid-Cap ETF (SCHM) at 5.75%. This indicates that BOUT's price experiences larger fluctuations and is considered to be riskier than SCHM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BOUT	SCHM	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.27%	5.75%	+2.52%
Volatility (6M) Calculated over the trailing 6-month period	17.22%	12.61%	+4.61%
Volatility (1Y) Calculated over the trailing 1-year period	21.92%	16.30%	+5.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.71%	19.67%	+0.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.00%	20.49%	+2.51%

BOUT vs. SCHM - Expense Ratio Comparison

BOUT has a 0.80% expense ratio, which is higher than SCHM's 0.04% expense ratio.

Dividends

BOUT vs. SCHM - Dividend Comparison

BOUT's dividend yield for the trailing twelve months is around 0.26%, less than SCHM's 1.22% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BOUT Innovator IBD Breakout Opportunities ETF	0.26%	0.34%	0.60%	1.32%	1.35%	0.00%	0.00%	0.00%	0.22%	0.00%	0.00%	0.00%
SCHM Schwab US Mid-Cap ETF	1.22%	1.46%	1.43%	1.50%	1.67%	1.13%	1.31%	1.48%	1.56%	1.27%	1.51%	1.54%

Frequently Asked Questions

Can I hold both BOUT and SCHM in my portfolio?

BOUT and SCHM have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BOUT or SCHM?

BOUT has higher volatility (8.27%) compared to SCHM (5.75%). In terms of maximum drawdown, BOUT dropped -36.98% vs SCHM's -42.43%.

Which ETF is better, BOUT or SCHM?

On 5-year performance, BOUT leads with 8.29% vs 8.08% for SCHM. On fees, SCHM is cheaper at 0.04% per year. On volatility, SCHM has been the lower-risk option at 5.75%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BOUT or SCHM?

Over the 5-year period, BOUT has performed better with a 8.29% return vs 8.08%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BOUT or SCHM?

SCHM is cheaper with a 0.04% expense ratio, compared with 0.80% for BOUT.

Which ETF pays a higher dividend yield, BOUT or SCHM?

SCHM has the higher dividend yield at 1.22%, compared with 0.26% for BOUT.

What is the main difference between BOUT and SCHM?

BOUT is categorized as Mid Cap Growth Equities, while SCHM is Mid Cap Blend Equities. BOUT tracks IBD Breakout Stocks Total Return Index, while SCHM tracks Dow Jones US Total Stock Market Mid-Cap. They also come from different issuers: Innovator and Charles Schwab. Their fees differ too: 0.80% for BOUT and 0.04% for SCHM.

Which has better risk-adjusted returns?

SCHM currently has the higher Sharpe Ratio (1.93 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.